home / stock / veru / veru quote
Last: | $1.32 |
---|---|
Change Percent: | -1.96% |
Open: | $1.3 |
Close: | $1.32 |
High: | $1.38 |
Low: | $1.28 |
Volume: | 1,530,167 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.32 | $1.3 | $1.32 | $1.38 | $1.28 | 1,530,167 | 04-24-2024 |
$1.275 | $1.29 | $1.275 | $1.48 | $1.27 | 2,628,979 | 04-23-2024 |
$1.27 | $1.35 | $1.27 | $1.355 | $1.25 | 1,409,523 | 04-22-2024 |
$1.31 | $1.39 | $1.31 | $1.55 | $1.3 | 2,614,224 | 04-19-2024 |
$1.42 | $1.14 | $1.42 | $1.425 | $1 | 7,020,042 | 04-18-2024 |
$1.16 | $1.25 | $1.16 | $1.28 | $1.125 | 2,515,342 | 04-17-2024 |
$1.255 | $1.42 | $1.255 | $1.44 | $1.24 | 3,202,965 | 04-16-2024 |
$1.53 | $1.51 | $1.53 | $1.53 | $1.11 | 7,167,729 | 04-15-2024 |
$1.52 | $1.81 | $1.52 | $1.85 | $1.41 | 6,387,484 | 04-12-2024 |
$1.79 | $1.27 | $1.79 | $1.92 | $1.26 | 17,815,835 | 04-11-2024 |
$1.24 | $1.14 | $1.24 | $1.24 | $1.05 | 2,465,179 | 04-10-2024 |
$1.17 | $1.06 | $1.17 | $1.25 | $1.04 | 6,189,847 | 04-09-2024 |
$1.03 | $0.95 | $1.03 | $1.09 | $0.9 | 3,374,199 | 04-08-2024 |
$0.9251 | $0.83 | $0.9251 | $0.93 | $0.8299 | 2,449,070 | 04-05-2024 |
$0.83 | $0.8224 | $0.83 | $0.8799 | $0.8 | 1,533,516 | 04-04-2024 |
$0.829 | $0.7847 | $0.829 | $0.85 | $0.775 | 2,945,658 | 04-03-2024 |
$0.7742 | $0.759 | $0.7742 | $0.78 | $0.6999 | 1,096,943 | 04-02-2024 |
$0.76 | $0.7168 | $0.76 | $0.77 | $0.67 | 2,280,503 | 04-01-2024 |
$0.7001 | $0.69 | $0.7001 | $0.7697 | $0.69 | 5,928,771 | 03-29-2024 |
$0.7001 | $0.69 | $0.7001 | $0.7697 | $0.69 | 5,928,771 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the P...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed) ...